CBIS Subsidiary, Cannabis Science Europe GmbH, Acquires

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
83
CBIS Subsidiary, Cannabis Science Europe GmbH, Acquires Majority Shares of German Bio Med GmbH Jinvator to Facilitate European Expansions, New Products, and Additional Clinical Studies

IRVINE, CA--(Marketwired - Apr 5, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in cannabis formulation-based drug development, is pleased to announce its subsidiary Cannabis Science Europe GmbH (CBIS EU) has acquired 74.9% of a German Bio Med Corporation "Jinvator Bio Med GmbH" (Jinvator), the creator of an ultra-sensitive rapid HIV/AIDS test based on nano-particle technology for the detection of HIV in the early stage of infection.

CBIS EU and Jinvator have agreed to immediately refine, develop, and bring the nanoGold test to market -- a product that expedites early HIV-testing without the risk of diagnostic gaps. Both Companies will mutually share the development of intellectual property and innovative advancements of bringing the technology to consumers now.

HIV/AIDS is one of the most severe epidemics of modern times, affecting 34 million patients globally. The prospect of being cured increases with early detection. Recent studies have shown that newborns, when timely diagnosed, can be cured from HIV/AIDS. Despite current tests being able to detect HIV within three months of infection with a 99% chance, the 1% uncertainty factor still remains. The nanoGold test aims to eliminate that risk by using nanotechnology to safely diagnose HIV within one week of infection. The highly-sensitive nanoGold test has the capability to detect a single virus in blood or saliva with a 10,000-fold dilution. The test is also suitable for diagnosing HIV in newborn babies.

"There is an enormous market for the nanoGold test, ranging from the general public, to diagnostic laboratories, blood banks, and hospitals. As an original and unrivaled testing kit designed for convenience and quick diagnosis, there is opportunity for the product to be well-received globally. In addition, the nanoGold test is produced to be more cost-effective for the consumer, in contrast to other related products on the market. Moreover, it can be performed and evaluated easily without technical aids," stated Jinvator President, Dr. R. S. Bhardwaj.

About Jinvator Bio Med GmbH

Jinvator Bio Med GmbH is a German Bio Medical Corporation that focuses on the production of pharmaceutical raw materials, development of therapeutics, medication, diagnostics and related products. The company assumes commercial and technological consulting and services for the biotechnological sector.

About Cannabis Science, Inc.

Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Cannabis Science, Inc. Dr. Allen Herman Chief Medical Officer (CMO) allen.herman@cannabisscience.com Tel: 1-888-263-0832 Cannabis Science, Inc. Mr. Raymond C. Dabney President & CEO, Co-Founder raymond.dabney@cannabisscience.com Tel: 1-888-263-0832 Cannabis Science, Inc. Investor Relations Teresa Misenheimer Email: teresa@cannabisscience.com Tel: 1-888-263-0832

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 135

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
Pinot's Palette Expands with New La Quinta Studio

Updated Category News Views 143

Canvas and Cabernet in Coachella Valley Grab your brushes and wine glasses; Pinot's Palette is branching out to La Quinta. As of November 27, locals and visitors alike can find their artistic flair at 47120 Dune Palms Road. This move isn’t just another business expansion—it's about blending community spirit with creativity, backed by the experienced entrepreneurs...

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 152

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 182

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 239

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 42

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 69

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 242

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Kinross Gold Faces Class Action Over Misleading Forecasts

Updated Category News Views 125

A Golden Opportunity Gone Wrong Well, it looks like Kinross Gold Corporation (NYSE: KGC) has stuck its foot in it again. This time, they're in hot water over claims that don't exactly hold up under scrutiny. If you're holding KGC, you've probably heard about the fresh class action lawsuit alleging they misled investors about their production targets. Naturally, the...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 123

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading

Top 5 Most Recently Viewed Articles

GIGABYTE Unveils Compact NVIDIA GeForce RTX 50 Series GPUs

Updated Category News Views 348

GIGABYTE Shines at CES with Revolutionary Graphics Card Launch The latest unveiling from GIGABYTE, a leader in innovative computer hardware, features their NVIDIA GeForce RTX™ 50 Series graphics cards. These models, including the GeForce RTX™ 5090, RTX™ 5090 D, RTX™ 5080, RTX™ 5070 Ti, and RTX™ 5070, promise to elevate gaming and creative experiences...

Continue Reading
EssilorLuxottica's Strategic Share Buyback Announcement Details

Updated Category News Views 246

EssilorLuxottica: Share Buyback Update Disclosure of transactions in own shares EssilorLuxottica has recently informed the public about its share buyback activities, following the authorization from its Annual Shareholders’ Meeting held on April 30, 2024. This initiative reflects the company's commitment to maintaining a healthy and robust stock market presence. Recent...

Continue Reading
Aker BP Announces Ex-Dividend Payment of USD 0.63 Today

Updated Category News Views 185

Understanding Aker BP's Ex-Dividend Payment Aker BP ASA has officially announced that its shares will commence trading ex-dividend today, marking a significant moment for investors. The ex-dividend amount is set at USD 0.63 per share, equivalent to NOK 6.36193. This announcement is crucial for shareholders looking to understand their financial returns from this reputable...

Continue Reading
PL Developments Secures FDA Nod for Omeprazole and Debt Restructure

Updated Category News Views 331

PL Developments Reaches Major Milestones With FDA Approval PL Developments (PLD), a leader in the healthcare sector, recently announced two substantial achievements: the FDA's approval for its Omeprazole OTC ANDA and the successful refinancing of its corporate debt. These milestones mark significant advancements in the company's ongoing efforts to innovate and grow....

Continue Reading
Akari Therapeutics Gears Up for Innovations in ADC Payloads

Updated Category News Views 237

Akari Therapeutics Gears Up for Innovations in ADC Payloads Akari Therapeutics, Plc (NASDAQ: AKTX), is making strides in the oncology biotechnology field, particularly with its progressive advancements in antibody drug conjugates (ADCs). Recently, the company released an insightful segment of the CEO Corner, which provides a comprehensive update on its initiatives and...

Continue Reading